Jefferies on Compass Pathways (CMPS): 'We remain 75-85%+ confident the FDA approves COMP360 (oral psilocybin) around YE:26/early 2027'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: CMPS) | Delayed: 11.18 -0.45 (3.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.63 | 52 Week High | $ | |||
| Open | $11.45 | 52 Week Low | $ | |||
| Day High | $11.52 | P/E | N/A | |||
| Day Low | $11.02 | EPS | $ | |||
| Volume | 1,159,104 | |||||
